MIRMRegulation•businesswire•
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sentiment:Negative (-10)
Summary
(NASDAQ:MIRM) FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 10, 2025 by businesswire